Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06510465
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-05-23
Brief Title:
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer NeoURANIA
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer NeoURANIA A Multi-center Prospective Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NeoURANIA
Brief Summary:
This study is a prospective multi-center single-arm two-cohort exploratory study aiming to explore the effectiveness and safety of neoadjuvant treatment with weekly utidelone combined with cisplatin in breast cancer patients
Detailed Description:
Explore the effectiveness and safety of neoadjuvant treatment with weekly utidelone combined with cisplatin in high risk early locally advanced and Inflammatory breast cancer patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None